| Literature DB >> 18448554 |
Edward L Trimble1, Sharon Thompson, Michaele C Christian, Lori Minasian.
Abstract
In 2006, i.p. chemotherapy re-emerged as a controversial topic in debates about the optimal treatment for women with advanced epithelial ovarian cancer. In this paper, we address the rationale behind i.p. chemotherapy, the data supporting its use, the selection of appropriate patients for i.p. chemotherapy, how best to avoid and manage the toxicities observed with i.p. chemotherapy, and directions for future research.Entities:
Mesh：
Substances：
Year: 2008 PMID： 18448554 DOI： 10.1634/theoncologist.2007-0058
Source DB: PubMed Journal: Oncologist ISSN： 1083-7159